Rocket


News + Filings
Transactions





Graham G. Walmsley

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
09/19/2023Akero Therapeutics, Inc.AKROPurchaseCommon Stock400k$26.00$10.4MSee Footnote09/19/2022
08/08/2023Akero Therapeutics, Inc.AKROPurchaseCommon Stock25k$42.06$1.1MSee Footnote08/08/2023
05/19/2023Akero Therapeutics, Inc.AKROPurchaseCommon Stock120k$42.00$5MSee Footnote09/19/2022
05/19/2023Akero Therapeutics, Inc.AKROPurchaseCommon Stock120k$42.00$5MSee Footnote09/19/2022
09/19/2022Akero Therapeutics, Inc.AKROPurchaseCommon Stock400k$26.00$10.4MSee Footnote09/19/2022
06/17/2022Olema Pharmaceuticals, Inc.OLMAGrantStock Option (right to buy)21.5k$0.00$0 06/17/2022
06/16/2022Olema Pharmaceuticals, Inc.OLMAGrantStock Option (right to buy)21.5k$3.43$73.8k 06/16/2022
06/02/2022Akero Therapeutics, Inc.AKROGrantStock Option (Right to Buy)15k$8.13$122k 06/02/2022
06/11/2021ALX ONCOLOGY HOLDINGS INCALXOGrantStock option (right to buy)12k$59.66$716.2k 06/11/2021
06/09/2021Olema Pharmaceuticals, Inc.OLMAGrantStock Option (right to buy)21.5k$27.66$595.2k 06/09/2021
06/01/2021Akero Therapeutics, Inc.AKROGiftStock Option (Right to Buy)13k$25.20$327.6k 06/01/2021
06/01/2021Akero Therapeutics, Inc.AKROGiftStock Option (Right to Buy)23.8k$19.97$475.9k 06/01/2021
06/01/2021Akero Therapeutics, Inc.AKROGiftStock Option (Right to Buy)13k$26.32$342.2k 06/01/2021
06/01/2021Akero Therapeutics, Inc.AKROGrantStock Option (Right to Buy)13k$26.32$342.2k 06/01/2021
12/14/2020ALX ONCOLOGY HOLDINGS INCALXOPurchaseCommon Stock20k$76.00$1.5MSee footnote12/14/2020
11/23/2020Olema Pharmaceuticals, Inc.OLMAConversionSeries C Convertible Preferred Stock1.2M$0.00$0See Footnote11/23/2020
11/23/2020Olema Pharmaceuticals, Inc.OLMAConversionSeries B Convertible Preferred Stock1.4M$0.00$0See Footnote11/23/2020
11/23/2020Olema Pharmaceuticals, Inc.OLMAPurchaseCommon Stock1.2M$19.00$22MSee Footnote11/23/2020
11/23/2020Olema Pharmaceuticals, Inc.OLMAConversionCommon Stock1.2M$0.00$0See Footnote11/23/2020
11/23/2020Olema Pharmaceuticals, Inc.OLMAConversionCommon Stock1.4M$0.00$0See Footnote11/23/2020
11/18/2020Olema Pharmaceuticals, Inc.OLMAGrantStock Option (Right to Buy)21.5k$19.00$408.9k 06/01/2020
09/30/2020Olema Pharmaceuticals, Inc.OLMAPurchaseSeries C Convertible Preferred Stock1.2M$11.06$13.1MSee Footnote06/01/2020
07/21/2020ALX ONCOLOGY HOLDINGS INCALXOConversionCommon Stock2.1M$0.00$0See footnote07/21/2020
07/21/2020ALX ONCOLOGY HOLDINGS INCALXOPurchaseCommon Stock975k$19.00$18.5MSee footnote07/21/2020
07/21/2020ALX ONCOLOGY HOLDINGS INCALXOConversionSeries C Convertible Preferred Stock2.1M$0.00$0See footnote07/21/2020
07/16/2020ALX ONCOLOGY HOLDINGS INCALXOGrantStock Option (right to buy)24k$19.00$456.2k 07/16/2020
06/01/2020Olema Pharmaceuticals, Inc.OLMAPurchaseSeries B Convertible Preferred Stock339.6k$4.71$1.6MSee Footnote06/01/2020
06/01/2020Akero Therapeutics, Inc.AKROGrantStock Option (Right to Buy)13k$25.20$327.6k 06/01/2020
06/01/2020Olema Pharmaceuticals, Inc.OLMAPurchaseSeries B Convertible Preferred Stock339.6k$4.71$1.6MSee Footnote06/01/2020
03/30/2020Akero Therapeutics, Inc.AKROExerciseCommon Stock2.2k$19.97$43.3k 03/30/2020
11/08/2019Akero Therapeutics, Inc.AKROExerciseStock Option (Right to Buy)2.2k$19.97$43.3k 03/30/2020
11/08/2019Akero Therapeutics, Inc.AKROGrantStock Option (Right to Buy)26k$19.97$519.2k 11/08/2019

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy